About Mediflorence
Mediflorence is a Healthcare company. Pharmaceutical manufacturing, marketing, and distribution of medicines in India. Its Indian entity Mediflorence Medicaments Limited reported revenue of ₹5.62 Cr. Mediflorence offers products and services including Tablets and Syrups. Its focus areas include Pharmaceuticals, Drug Manufacturing, Prescription Medicines and Tablets and Injections.
Company details
Mediflorence is established as a pharmaceutical company by a group of technocrats with extensive experience in manufacturing, marketing, sales, finance, and distribution logistics. It is headquartered in Delhi with a zonal office in Meerut, and a collaboration exists with Florence Corporation in the USA for technical expertise. The company is recognized for developing scientifically innovative products that emphasize quality and benefit humanity, while innovative items like cardioprotectors are currently under trial. Principles of honesty and integrity are embedded in its operations, and it serves various health sectors through tablets, syrups, and capsules.
- SectorsHealthcare
- Email••••••••
- Legal Name Mediflorence Medicaments Ltd
- Date of Incorporation 09 Feb, 2012
- Jurisdiction New Delhi, Delhi, India
- Indian entity revenue₹5.62 Cr
FY 2025 · +6% YoY
- Indian entity net profit₹3.3 Lakh
FY 2025 · 1% margin
- Indian entity EBITDA₹11 Lakh
FY 2025 · 2% margin
Associated legal entities of Mediflorence
Mediflorence operates through Mediflorence Medicaments Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Mediflorence Medicaments Limited CIN U24100DL2012PLC231292 | Active | 09 Feb 2012 | New Delhi, Delhi | ₹5.6 Cr | 4 | View details |
Products & Services of Mediflorence
Mediflorence offers a comprehensive portfolio of products and services, including Tablets and Syrups.
Various tablets are manufactured and distributed by Mediflorence for conditions such as cardiovascular diseases and pain relief.
Syrups are produced by Mediflorence for respiratory and other health issues, including formulations like Clariment Syrup.
Board of directors of Mediflorence Medicaments Limited (Mediflorence)
Mediflorence Medicaments Limited is the primary company behind Mediflorence. The board of Mediflorence Medicaments Limited currently have 4 directors; the longest-serving is Sunil Kumar Sharma, appointed in 2012. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sunil Kumar Sharma DIN 01936871 | Director | 09 Feb 2012 | 14 yrs 8 mo | Mediflorence Medicaments Limited |
| Bijender Kumar Jain DIN 00740538 | Director | 09 Feb 2012 | 14 yrs 8 mo | Mediflorence Medicaments Limited |
| Nishant Agrawal DIN 06645323 | Director | 30 Sep 2013 | 13 yrs | Mediflorence Medicaments Limited |
| Vibhu Sharma DIN 09115158 | Director | 15 Mar 2021 | 5 yrs 7 mo | Mediflorence Medicaments Limited |
Financials of Mediflorence
Figures of Mediflorence Medicaments Limited, the primary company behind Mediflorence, for FY 2025. Revenue was ₹5.62 Cr (+6% year on year). Net profit was ₹3.3 Lakh (1% margin). EBITDA was ₹11 Lakh (2% margin). Revenue has grown at a compounded annual rate of +11% over three years and +13% over five years.
- ₹5.62 CrRevenue · FY 2025 · +6% YoY
- ₹3.3 LakhNet profit · 1% margin
- ₹11 LakhEBITDA · 2% margin
- ₹10 LakhPaid-up capital
- +11%Revenue CAGR, 3 years
- +13%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Mediflorence Medicaments Limited are on its company page.
Detailed financial statements for Mediflorence
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Mediflorence
The primary company behind Mediflorence, Mediflorence Medicaments Limited, reported revenue of ₹5.62 Cr for FY 2025, up 6% year on year.
Mediflorence is established as a pharmaceutical company by a group of technocrats with extensive experience in manufacturing, marketing, sales, finance, and distribution logistics. It is headquartered in Delhi with a zonal office in Meerut, and a collaboration exists with Florence Corporation in the USA for technical expertise. The company is recognized for developing scientifically innovative products that emphasize quality and benefit humanity, while innovative items like cardioprotectors are currently under trial. Principles of honesty and integrity are embedded in its operations, and it serves various health sectors through tablets, syrups, and capsules.
Mediflorence offers Tablets and Syrups.
Mediflorence operates through Mediflorence Medicaments Limited.
The legal entities of Mediflorence currently have 4 directors, including Sunil Kumar Sharma, Vibhu Sharma, Nishant Agrawal and others.